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Aloxe3 Knockout Mice Reveal a Function of
Epidermal Lipoxygenase-3 as Hepoxilin Synthase
and Its Pivotal Role in Barrier Formation
Peter Krieg1, Sabine Rosenberger1, Silvia de Juanes1, Susanne Latzko1, Jin Hou2, Angela Dick2,
Ulrich Kloz3, Frank van der Hoeven3, Ingrid Hausser4, Irene Esposito5, Manfred Rauh2,6 and
Holm Schneider2,6
Loss-of-function mutations in the lipoxygenase (LOX) genes ALOX12B and ALOXE3 are the second most
common cause of autosomal recessive congenital ichthyosis. The encoded proteins, 12R-LOX and epidermal
LOX-3 (eLOX-3), act in sequence to convert fatty acid substrates via R-hydroperoxides to specific epoxyalcohol
derivatives and have been proposed to operate in the same metabolic pathway during epidermal barrier
formation. Here, we show that eLOX-3 deficiency in mice results in early postnatal death, associated with similar
but somewhat less severe barrier defects and morphological changes than reported earlier for the 12R-LOX-
knockout mice. Skin lipid analysis demonstrated that the severity of barrier failure is related to the loss of
covalently bound ceramides in both 12R-LOX- and eLOX-3-null mice, confirming a proposed functional linkage
of the LOX pathway to ceramide processing and formation of the corneocyte lipid envelope. Furthermore,
analysis of free oxygenated fatty acid metabolites revealed strongly reduced levels of hepoxilin metabolites in
eLOX-3-deficient epidermis, indicating an additional function of eLOX-3 in mammalian skin as a hepoxilin
synthase linked to the 12S-LOX pathway.
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INTRODUCTION
Autosomal recessive congenital ichthyosis (ARCI) are a
clinically and genetically heterogeneous group of severe
keratinization disorders with an estimated prevalence of 1 in
100,000 newborns (Oji and Traupe, 2006). Most of the patients
are born as collodion babies. Later, the main symptoms are
widespread scaling of the skin and varying degrees of erythema.
To date, mutations in eight different genes have been identified
to cause the described phenotype, among them are the
lipoxygenase (LOX) genes ALOX12B and ALOXE3. The cor-
responding proteins have been proposed to be involved in the
formation of the permeability barrier of the skin, an important
protection against water loss and physical injury.
ALOX12B and ALOXE3 encode the lipoxygenases 12R-
LOX and epidermal LOX-3 (eLOX-3), respectively. Both are
members of the epidermal subfamily of mammalian LOX
with preferential expression in the skin and several other
epithelial tissues (Krieg et al., 2002). LOXs constitute a
widespread family of non-heme iron dioxygenases that insert
molecular oxygen into polyunsaturated fatty acids, producing
highly active lipid mediators (Brash, 1999). 12R-LOX and
eLOX-3 differ from all other LOXs by unusual structural and
enzymatic features. 12R-LOX represents the only mammalian
LOX that forms products with R-chirality, and eLOX-3
functions as a hydroperoxide isomerase by exhibiting only
latent dioxygenase activity (Kinzig et al., 1999; Krieg et al.,
1999; Yu et al., 2003; Zheng and Brash, 2010). Both enzymes
act in sequence to convert fatty acid substrates via R-
hydroperoxides to specific epoxyalcohol derivatives. With
arachidonic acid as substrate, the 12R-LOX/eLOX-3 pathway
results in the production of a specific R-epoxyalcohol of the
hepoxilin family, members of which are known to function as
signaling molecules (Brash et al., 2007). Recent studies
suggested a structural role of the 12R-LOX/eLOX-3 pathway
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via processing of o-hydroxy acylceramides as a prerequisite
for the formation of the corneocyte lipid envelope (CLE)
(Zheng et al., 2011).
Mutations in ALOX12B or ALOXE3 have been detected in
B15% of ARCI patients and represent the second most
common cause of ARCI (Eckl et al., 2009; Fischer, 2009).
Studies of our group and others demonstrated that such
mutations may completely abolish the catalytic activity of the
respective LOX enzymes (Eckl et al., 2005; Yu et al., 2005).
In previous studies, we and others showed that inactiva-
tion of 12R-LOX in mice leads to neonatal death due to a
severely impaired permeability barrier function (Epp et al.,
2007; Moran et al., 2007). Our studies showed that the
defective barrier function of neonatal 12R-LOX-knockout
skin is associated with ultrastructural anomalies in the upper
granular layer, impaired processing of profilaggrin to filaggrin
monomers, and disordered composition of ester-bound
ceramide species. The mature 12R-LOX-deficient mouse
skin, as analyzed in skin grafts, developed an ichthyosiform
phenotype that closely resembled the phenotype observed in
ichthyosis patients (de Juanes et al., 2009).
In this study, we generated and analyzed Aloxe3-null mice
that display a lethal phenotype associated with severe skin
barrier dysfunction, which is similar to that observed in 12R-
LOX-knockout mice. The pivotal role of the 12R-LOX/eLOX-
3 pathway for the establishment of the epidermal barrier
function can be traced back to the oxygenation of linoleate-
containing ceramides, which constitutes an important step in
the construction of CLE and barrier formation. Moreover, the
data indicate an additional role of eLOX-3 in epidermal
eicosanoid signaling.
RESULTS
Postnatal death and loss of skin barrier function in mice
lacking eLOX-3
For targeting the Aloxe3 gene, we chose a conditional gene-
targeting approach utilizing the Cre-loxP and flp-FRT
systems. A targeting construct was prepared and eLOX-3-
null mice were generated as described in Supplementary
Figure S1a online and under Supplementary Materials and
Methods online. The genotypes of the eLOX-3 null mice were
determined by PCR and Southern blot analysis (Supplemen-
tary Figure S1a–c online). RT-PCR, western blot analysis, and
immunofluorescence revealed no expression of eLOX-3 wild-
type mRNA and the absence of eLOX-3 protein in eLOX-3/
mice (Supplementary Figure S1d and e online, Figure 3).
On the basis of proposed close functional relationship of
both enzymes in barrier formation, we expected the eLOX-3-
deficient mice to show a similar lethal phenotype as observed
earlier in12R-LOX-knockout mice (Epp et al., 2007). Whereas
heterozygous animals (eLOX-3þ /) were phenotypically
indistinguishable from wild-type mice and reproduced
normally, eLOX-3/ mice were born at the expected
Mendelian ratio, but died within 5–12 hours after birth owing
to defective skin barrier function. Weighing revealed that
eLOX-3/ mice lost around 2.5% of body weight per hour,
whereas their heterozygous and wild-type littermates
maintained weight (Figure 1a). Dehydration through the
skin was assessed by measuring transepidermal water loss
(TEWL). Homozygous mutant mice showed approximately 4-
fold increased TEWL compared with control littermates
(Figure 1b).
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Figure 1. Loss of epidermal barrier function in epidermal lipoxygenase-3 (eLOX-3)-deficient mice. (a) Dehydration over time. Data are presented as percentage
of initial body weight of wild-type (þ /þ ), heterozygous (þ /), and homozygous (/) mutant mice (n¼5 for each genotype). Only homozygous mutants
showed a weight loss ofB3% per hour. (b) Transepidermal water loss (TEWL) measured on the lateral surface of newborn wild-type (þ /þ , n¼ 9), heterozygous
(þ /, n¼ 18), and homozygous (/, n¼ 16) mutant mice. (c) Barrier-dependent dye exclusion assay on wild-type and eLOX-3 mutant mice at the ages
indicated. In control embryos, a decrease of skin permeability was observed from E16.5 to E18.5 as the barrier is acquired in the dorsal to ventral pattern,
whereas eLOX-3-knockout embryos remained completely stained. ****Pp0.0001.
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We assessed outside-in barrier acquisition during
embryonic development by performing a whole-mount skin
toluidine blue penetration assay (Hardman et al., 1998). In
wild-type animals, the staining reflects a dorsal to ventral
pattern of decreasing skin permeability with proceeding
barrier development between embryonic day 16.5 and 17.5,
coming to a halt on embryonic day 18.5 when the skin has
become completely impermeable. Skin of homozygous
mutant mice, in contrast, remained permeable as indicated
by intense staining (Figure 1c). We also investigated the
barrier function of tight junctions by injecting biotin
subcutaneously into newborn mice and measuring its
diffusion into the epidermis. Prevention of diffusion was
observed in the upper granular cell layer of the skin of both
homozygous mutant mice and wild-type mice, indicating that
eLOX-3 deficiency did not affect the barrier function of tight
junctions (not shown).
Structural abnormalities of the skin of eLOX-3-deficient mice
The skin of eLOX-3/ newborns closely resembled the
phenotype observed earlier in 12R-LOX-knockout mice. The
stratum corneum appeared to be more tightly packed than in
control skin (Figure 2a and b), whereas no significant
differences were observed in the basal, spinous, or granular
layers. At the ultrastructural level, electron microscopy
revealed hyperkeratosis of the skin of eLOX-3-deficient mice
as indicated by the presence of very compact horny layers
(Figure 2d). Furthermore, we noticed an increased occur-
rence of transition cells underlying the stratum corneum
and occasionally irregular tubulus-like structures in the
horny layers, indicating defects or delay of the desquama-
tion process in the skin of eLOX-3-knockout animals
(Figure 2e and f). The characteristic vacuole-like structures
observed earlier in the granular layers of neonatal 12R-
LOX-deficient skin, however, could not be detected in the
skin of eLOX-3/ mice.
Epidermal differentiation
To unveil defects in epidermal differentiation, we studied
the distribution as well as the expression levels of
differentiation markers. Immunofluorescence staining was
performed on the back skin of newborn mice using the
following markers: keratin 14, keratin 10, keratin 6, filaggrin,
involucrin, loricrin, and repetin. No obvious alterations
of the expression pattern could be detected for keratins
10 and 14, involucrin, or repetin. Keratin 6 staining,
however, which was found to be restricted to hair follicles
in wild-type mice, was strongly increased in basal keratino-
cytes of eLOX-3-deficient animals (Figure 3). The near-
normal expression of the early and late differentiation
markers was confirmed by western blot analysis, which
also indicated that processing of profilaggrin to filaggrin
monomers was not disturbed in eLOX-3-knockout skin—in
contrast to neonatal 12R-LOX-deficient skin that completely
lacks mature filaggrin monomers (not shown). In summary,
except for keratin 6 none of the early, intermediate, and late
differentiation markers analyzed were altered in eLOX-3-
deficient mice.
Altered lipid composition
As lipid analysis of the skin from 12R-LOX-deficient mice had
revealed a significant decrease of protein-bound o-hydro-
xyceramides, whereas other lipid components had remained
unchanged, we assumed that loss of these covalently bound
ceramide species, which are the major constituents of the
CLE and thus essential for permeability barrier function,
would be mainly responsible for epidermal barrier failure.
Bringing forward a new model of the assumed role of the
12R-LOX/eLOX-3 pathway in skin barrier function, Brash and
colleagues recently suggested that oxygenation of the
linoleate-containing esterified omega-hydroxyacyl-sphingo-
sine (EOS) ceramides by 12R-LOX and eLOX-3 is required to
facilitate hydrolysis and subsequent covalent linkage of the
o-hydroxyceramides to proteins of the cornified envelope
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Figure 2. Structural skin abnormalities of epidermal lipoxygenase-3
(eLOX-3)-deficient mice. Representative skin sections from (a) newborn
wild-type and (b) eLOX-3/ littermates stained with hematoxylin–eosin.
The staining shows a more tightly packed stratum cormeum but otherwise
normally stratified organization of keratinocytes in knockout mouse skin.
Electron microscopy of skin from (c) control and (d–f) eLOX-3/ neonates.
(d) Stratum corneum of mutant skin. Note the markedly piled-up cornified
cells. (e) Accumulation of transition cells (asterisk) that underlay the stratum
corneum. (f) Irregular tubular-like structures in the horny lamellae (arrow)
may indicate defects or delay of the desquamation process. Bars¼100 mm for
a and b; 2,500 nm for c–e; and 250 nm for f.
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(CE) (Zheng et al., 2011). To test this hypothesis in our
eLOX3-knockout model, we analyzed the ceramide compo-
sition of the epidermis of control and mutant mice by thin-
layer chromatography (TLC) and high-performance liquid
chromatography-tandem mass spectrometry (HPLC-MS/MS).
TLC analysis revealed no differences in the levels of free
lipids (Figure 4a), whereas the subfractions of ester-bound
ceramides differed significantly between control and knock-
out mice: they were strongly reduced in eLOX-3-deficient
epidermis but completely lost in 12R-LOX-knockout mice
(Figure 4b). We next evaluated the total amount of o-
hydroxyacyl-sphingosine ceramides Cer[OS (18)] by HPLC-
MS/MS (Figure 4c). Both in eLOX-3/ and 12R-LOX/mice
omega-hydroxyacyl-sphingosine (OS) formation was clearly
lower than in the wild type. However, 12R-LOX-deficient
animals showed a more distinct reduction. Cer[OS (18)]
levels of heterozygous animals did not differ significantly
from those of wild-type mice. The observed difference
between eLOX-3/ and 12R-LOX/ mice became more
evident when looking at different ceramide species that vary
in the length of their long-chain fatty acid (Figure 4d). In
eLOX-3/ mice, levels of ceramides with fatty acids
containing 30 or 32 carbon atoms were not significantly
lower than in heterozygous or control animals, whereas 12R-
LOX-deficient mice showed a marked reduction of all OS
species investigated.
To clarify the impact of eLOX-3 on eicosanoid signaling,
relevant free lipids of the epidermis of newborn mutant mice
were further investigated by HPLC-MS/MS (Figure 4e and f).
Knockout of eLOX-3 had no detectable influence on the
concentrations of the linoleic acid–derived LOX products, 9-
hydroxyoctadecadienoic acid and 13-hydroxyoctadecadienoic
s.c.
eLOX-3
+/+
12R-LOX
K6
+/+
+/+
K14
+/+
K10
+/+
K10
–/–
Rptn
+/+
Rptn
–/–
K14
–/–
IvI
+/+
IvI
–/–
K6
–/–
Flg
+/+
Flg
–/–
12R-LOX
–/–
eLOX-3
–/–
s.g.
s.s.
s.b.
s.c.
s.g.
s.s.
s.b.
Figure 3. Detection of epidermal lipoxygenase-3 (eLOX-3), 12R-LOX, and epidermal differentiation markers in the skin from control and eLOX-3-deficient
mice. Skin sections from control and eLOX-3/ mice were immunostained for the indicated proteins. Nuclei are counterstained with Hoechst 33258.
Specific staining (arrows) for eLOX-3 is observed in keratinocytes of the granular layers of wild-type mice but absent in mutants, whereas a similar staining
pattern for 12R-LOX is unaffected. Note that except for keratin 6 (K6) where staining is seen in basal layers of mutant skin but restricted to hair follicles in
wild-type mice, keratin 14 and 10 (K14, K10), filaggrin (Flg), involucrin (Ivl), and repetin (Rptn) staining is found at the typical localizations and at similar
intensities in control and mutant skin. s.b., stratum basale; s.c., stratum corneum; s.g., stratum granulosum; s.s., stratum spinosum. Bars¼ 20mm.
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acid, and the arachidonic acid–derived LOX product, 15-
hydroxyeicosatetraenoic acid (15-HETE), whereas higher
amounts of 12-HETE were detected in eLOX-3/ epidermis
than in the samples from heterozygous or wild-type mice
(Figure 4e). As mouse 12R-LOX does not metabolize free
arachidonic acid, but only esterified substrates (Siebert et al.,
2001), we speculated that 12-HETE detected in mouse skin
is not a 12R-LOX product. Indeed, chiral analysis revealed
this to be exclusively 12(S)-HETE, indicating that loss of
eLOX-3 activity results in an accumulation of this eicosanoid
derived from the 12(S)-LOX pathway (Figure 4f). The 12-LOX
pathway is bifurcated at the level of its primary product
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Figure 4. Lipid analysis of the epidermis of epidermal lipoxygenase-3/ (eLOX-3/) and 12R-LOX/ mice. (a, b) Thin-layer chromatography (TLC) analysis
of free and ester-linked lipids from epidermis samples of newborn eLOX-3- or 12R-LOX-deficient and control mice. The ceramide nomenclatures used in this
figure are as suggested previously (Motta et al., 1993). The positions of comigrating standards are indicated. (c, d) Protein-bound ceramides were investigated by
high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Results were normalized to epidermal tissue weight and displayed in
relation to the wild-type mice. (c) Peak areas of ceramide species were combined and normalized to epidermal weight. (d) Amounts of individual OS species that
differ in the length of the fatty acid attached. (e, f) Levels of free LOX products in the epidermis of eLOX-3/mice. (e) Relative amounts of different linoleic acid–
and arachidonic acid–derived LOX products were determined by HPLC-MS/MS. The results were normalized to epidermal tissue weight. (f) Epidermis samples
were further analyzed by chiral HPLC, which indicated that 12-hydroxyeicosatetraenoic acid (12-HETE) was exclusively in S-configuration. AS, ceramide AS;
Chol, cholesterol; c.p.s, counts per second; HODE, hydroxyoctadecadienoic acid; NS, ceramide NS; OS, ceramide OS. **Pp0.01; ***Pp0.001.
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12-hydroperoxyeicosatetraenoic acid (12-HPETE), which can
either be reduced to 12-HETE or converted to hepoxilins.
Metabolites of this pathway such as hepoxilin B3, trioxilin
A3, and trioxilin B3 were found to be strongly reduced in
eLOX-3/ mice (Figure 6a). In 12R-LOX-deficient epidermis,
in contrast, no alterations in the levels of hepoxilin metabolites
were detected (data not shown). This indicates an important
role of eLOX-3 in the respective hepoxilin signaling cascade
and reveals an additional function of eLOX-3 in mammalian
skin as a hepoxilin synthase (Figure 5).
DISCUSSION
Loss-of-function mutations in the LOX genes ALOX12B and
ALOXE3 are among the most frequent causes of ARCI.
Knockout of these LOX genes in the mouse models described
here and in previous reports confirm a close functional
relationship of the corresponding LOX enzymes, 12R-LOX
and eLOX-3, and their essential role in skin barrier formation.
In both models, the mice die soon after birth owing to severe
TEWL. Our data show that eLOX-3-deficient mice exhibit
similar but somewhat less severe barrier defects than reported
earlier for 12R-LOX-knockout mice (Epp et al., 2007),
indicated by weight loss (2.5% per hour vs 10%), increase
in TEWL (4-fold vs 8-fold), and a maximum life span of about
12 vs 3 hours.
The typical histological phenotype of skin from ichthyosis
patients is characterized by variable epidermal hyperplasia
and marked hyperkeratosis, and is thought to result
from a physical compensation for the defective cutaneous
permeability barrier required for survival in a terrestrial
environment. The macroscopic appearance of both 12R-
LOX/ and eLOX-3/ mouse skin resembles that of mutant
human skin albeit at different degrees. Indeed, previous
skin grafting studies confirmed that matured 12R-LOX-
deficient skin developed an ichthyosiform phenotype similar
to that seen in severe ichthyosis (de Juanes et al., 2009).
Although our electron microscopy studies revealed less
pronounced structural abnormalities in the skin of eLOX-3-
deficient mice than in 12R-LOX/ skin, they clearly
indicated the onset of compensatory hyperkeratosis and
defects or delay of the desquamation process. Similarly,
ectopic interfollicular expression of keratin 6 in neonatal
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eLOX-3/ skin as shown by immunofluorescence may be
indicative of hyperproliferation.
This study provides insights into the mechanisms by which
loss of eLOX-3 function might affect epidermal barrier and
skin homeostasis. Unlike all other members of the LOX
family, eLOX-3 displays only latent dioxygenase activity but
exhibits a dominant hydroperoxide isomerase activity that
converts fatty acid hydroperoxides, the usual LOX products—
preferentially products of 12R-LOX—to epoxyalcohols and
ketones. Although initially a function of the 12R-LOX/eLOX-3
enzyme sequence in eicosanoid signaling was hypothesized,
a recent study linked the 12R-LOX/eLOX-3 pathway to skin
ceramide processing and consequently to the formation of the
CLE (Zheng et al., 2011). The study showed that linoleate-
containing EOS ceramide is a natural substrate for the
12R-LOX/eLOX-3 pathway being oxygenated by consecutive
actions of 12R-LOX and eLOX-3 to a 9R-hydroperoxide-
and a corresponding 9R,10R-epoxy-13R-hydroxy-derivative.
The model suggests that the LOX-catalyzed oxygenation
facilitates hydrolysis of the oxidized linoleate moiety result-
ing in a free o-hydroxyl on the ceramides for coupling to the
cross-linked proteins of the CE. Cross-linked OS ceramides
and o-hydroxy very long-chain fatty acids are the major
constituents of the CLE that surrounds the corneocyte, and the
covalent coupling is an important step in sealing the water
barrier.
The results of our study are in line with the model of Zheng
et al. and provide further evidence for a consecutive
oxygenation of the linoleate esterified in EOS by 12R-LOX
and eLOX-3. Lipid analysis showed a significant decrease of
covalently bound OS ceramide species in eLOX-3-deficient
skin, with a reduction of the total amount of bound ceramides
to half of the wild-type level, whereas in 12R-LOX-deficient
mice a reduction to less than 10% of the wild-type level was
observed. The less pronounced loss of ester-bound ceramides
in eLOX-3/ mice may be explained by a 12R-LOX-
mediated partial oxidation of the linoleate moiety to a 9R-
hydroperoxide derivative, which may permit a reduced
hydrolysis of the linoleate and subsequent covalent linkage
of resultant o-hydroxy ceramides, whereas interruption of the
first oxidation step by 12R-LOX deficiency completely
prevents hydrolysis of the EOS ceramides. The loss of bound
ceramides is accompanied by barrier defects of increasing
severity in the different mouse models, indicating that loss of
ceramide binding may be the main cause of epidermal barrier
failure in the mutant mice. It remains to be elucidated
whether the free oxygenated cleavage products may have
signaling functions in barrier formation or other aspects of
skin physiology beyond those hypothesized recently (Brash
et al., 2007).
Analysis of the free oxygenated fatty acid metabolites
furthermore revealed strongly reduced levels of different
hepoxilin metabolites (the trihydroxy hydrolysis product of
the unstable hepoxilin A3 as well as hepoxilin B3 and its
corresponding triols) in eLOX-3-deficient skin, indicating an
additional function of eLOX-3 as a hepoxilin synthase in
mammalian skin. We report on the presence of hepoxilin and
trioxilin in mouse skin, which to our knowledge is previously
unreported. Anton and Vila (2000) previously reported
elevated levels of endogenous hepoxilins and trioxilins in
human psoriatic scales and the biosynthesis of hepoxilin-type
products and their triol derivatives in isolated human
epidermal fragments (Anton et al., 1998).
Although the exact steric identification of the hepoxilin
metabolites in mouse skin remains to be established, the
hepoxilin B product had the same gas chromatography–mass
spectrometry characteristics as the synthetic standard of
10R-hydroxy-11S,12S-hepoxilin B3, which is the product
of eLOX-3-catalyzed transformation of 12S-HPETE (Yu
et al., 2003). Furthermore, reduction of hepoxilin metabo-
lite levels in eLOX-3-deficient epidermis was accompanied
by increased levels of 12-HETE, which was shown by
chiral analysis to be exclusively in the S-configuration.
Given the aforementioned inactivity of mouse 12R-LOX
toward free arachidonic acid, we conclude that the
hepoxilin metabolites are derived from 12S-HPETE formed
by platelet-type 12S-LOX and/or epidermal 12S-LOX, both
of which are expressed in the mouse epidermis (Heidt
et al., 2000).
Hepoxilins and their triol derivatives have been shown to
have a role in a variety of physiological processes, including
inflammation and neurotransmission. Most functions appear to
be mediated by influencing intracellular calcium concentrations
(Pace-Asciak, 2009). In the skin, various potential mechanisms
of action have been discussed for these metabolites including
effects on a putative membrane receptor, ichthyin (NIPAL4),
implicated through genetic studies in ichthyosis patients or
through activation of PPAR receptors (Lefevre et al., 2004; Yu
et al., 2007). Further research is required to determine the exact
mode of action and the physiological role of hepoxilin-type
metabolites in the epidermis.
Taken together, our data indicate signaling and structural
functions of eLOX-3 in the epidermis, as summarized in
Figure 5.
In addition to its function in the skin, eLOX-3 has also
been proposed to have a role in adipose tissue (Fu¨rstenberger
et al., 2007). This view is supported by our previous studies
demonstrating that eLOX-3 is critically involved in adipocyte
differentiation in vitro. The data suggest that eLOX-3, in
synergistic action with xanthine oxidoreductase, produces
hepoxilins that function as endogenous PPARg activators
capable of promoting early steps in the conversion of
preadipocytes into adipocytes (Hallenborg et al., 2010). In
this study, histological examination of homozygous and
heterozygous eLOX-3-knockout mice showed normal organ
development compared with control mice (not shown).
Furthermore, based on light microscopic inspection, no
alterations in brown and white adipose tissues could be
detected in neonatal mice, suggesting that eLOX-3 deficiency
had no effect on fetal adipose tissue development. A possible
role of eLOX-3 in adipose tissue in vivo at later develop-
mental stages and in metabolism under distinct physiolo-
gical conditions, however, remains to be elucidated. The
availability of the floxed eLOX-3 mice generated in this
study will help establish conditional knockout models with
inducible tissue-specific eLOX-3 inactivation for further
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studies of the physiological role of eLOX-3 in the skin and
adipose tissue.
In conclusion, this study provides evidence for a structural
role of the 12R-LOX/eLOX-3 pathway in skin barrier
formation where LOX-catalyzed oxygenation of the linoleate
moiety of ceramides constitutes an indispensable step for the
covalent linkage of hydroxyl ceramides to proteins of the CE
and subsequently for the formation of the CLE. Furthermore,
we unveiled an additional function of eLOX-3 linked to its
hepoxilin synthase activity and to the 12S-LOX pathway. The
impact of this hepoxilin pathway on skin physiology remains
to be elucidated.
MATERIALS AND METHODS
Generation and maintenance of eLOX-3-deficient mice
The eLOX-3-deficient mouse line was generated by targeted gene
disruptionas described in Supplementary Materials and Methods
online. The animal experiments were conducted in accordance with
the guidelines of the Arbeitsgemeinschaft der Tierschutzbeauftragten
in Baden-Wu¨rttemberg (Officials for Animal Welfare) and were
approved by the Regierungspra¨sidium Karlsruhe, Germany
(Az. G-46/06).
Antibodies
Rabbit polyclonal antipeptide antibodies detecting 12R-LOX and
eLOX-3, and mouse anti-12R-LOX mAb, have been described earlier
(Epp et al., 2007). Rat anti-eLOX-3 mAbs were raised using
His-tagged eLOX-3 protein as immunogen. Other primary antibodies
used were goat anti-GAPDH (Santa Cruz Biotechnology, Heidel-
berg, Germany), rabbit anti-keratin 14, rabbit anti-keratin 10, rabbit
anti-keratin 6, rabbit anti-filaggrin, rabbit anti-involucrin (all Covance,
Princeton, NJ), and rabbit anti-repetin (gift from D Hohl). Secondary
antibodies included Alexa Fluor 488 goat anti-mouse IgG (Invitrogen,
San Diego, CA), Alexa Fluor 488 goat anti-rat IgG (Invitrogen), CY3
goat anti-rabbit IgG (Jackson ImmunoResearch, Suffolk, UK), and
horseradish peroxidase–conjugated anti-rabbit IgG (BD Biosciences,
Palo Alto, CA).
Epidermal protein extraction and western blot analysis
Trunk epidermis of newborn mice was separated mechanically from
the dermis following submersion in hot phosphate-buffered saline
(PBS) (56 1C) for 30 seconds and snap-frozen in liquid nitrogen.
Epidermal tissue was disintegrated for 30 seconds in a ball mill
(Micro-Dismembrator S, Sartorius, Go¨ttingen, Germany) at liquid
nitrogen temperature and then homogenized in lysis buffer contain-
ing 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 2mM EDTA,
10% glycerol, 150mM NaCl, 50mM Tris (pH 7.4), and protein
inhibitors (1mM phenylmethylsulfonylfluorid, aprotinin 1 mgml1
and leupeptin 1 mgml1). Western blot analysis was performed as
previously described (Epp et al., 2007).
Pathohistological evaluation
Neonatal mice were killed by decapitation, fixed in 4% para-
formaldehyde, and embedded in paraffin blocks for histological
evaluation. One-micrometer sections were cut and stained with
hematoxylin–eosin. Images of the sections were taken at  20
magnification with an automated slide scan microscope (dotSlide
System, Olympus, Hamburg, Germany).
Histological and immunofluorescence analysis
For light microscopic observation, samples were fixed with 4%
formalin in PBS for 24 hours, dehydrated in 70% ethanol, and then
embedded in paraffin. Five-micrometer sections were mounted on
slides, dewaxed, rehydrated, and stained with hematoxylin–eosin.
Sections were embedded in mounting medium (DakoCytomation,
Hamburg, Germany) and examined with an Axioskop 2 with a Zeiss
25 /0.8 Plan-Neofluar objective connected to an Axiocam camera
using the Axiovision software (release 3.2; Zeiss, Go¨ttingen,
Germany). For immunofluorescence microscopy, 3-mm cryosections
were fixed in acetone for 10minutes at 20 1C, permeabilized
with 0.5% Triton X-100 in PBS, blocked with 1% BSA in PBS for
20minutes, and incubated with the primary antibody for 1 hour.
After washing three times (10minutes each) with PBS, samples were
incubated with a fluorescent dye–labeled secondary antibody and
Hoechst 33258 for 30minutes, and washed as described above.
Images were acquired using a LSM 700 confocal microscope with an
EC Plan-Neofluar 40 /1.30 Oil DIC objective lens (Zeiss), the
software ZEN 2009 (v5.5.0.375; scan parameters 1,024 1,024
Pixel, speed 2, line average 2), and Adobe Photoshop CS3.
Functional analyses of the epidermal barrier
To determine the rate of fluid loss, newborn animals were separated
from their mothers and put on a heating pad set at 37 1C. Body weight
was monitored every 30minutes until homozygous mutant mice
died. The rate of TEWL from the skin of newborn mice was deter-
mined with a Tewameter (Courage and Khazaka, Cologne, Germany).
Toluidine blue staining of mouse embryos
The developmental stage of mouse embryos was determined based
on the assumption that fertilization occurred in the middle of the
dark cycle the day before plugs were identified. The embryos were
subjected to methanol dehydration and subsequent rehydration as
described previously (Hardman et al., 1998), washed with PBS for
1minute, and stained in 0.1% toluidine blue O/PBS for 30minutes.
After decoloration in PBS for 15minutes, the embryos were
photographed.
Electron microscopy
All specimens were fixed in a solution of 3% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.4, for at least 2 hours at room temperature,
cut into pieces ofB1mm3, washed in buffer, postfixed for 1 hour at
4 1C in 1% osmium tetroxide, rinsed with water, dehydrated through
graded ethanol solutions, transferred into propylene oxide, and
embedded in epoxy resin (glycidether 100). Ultrathin sections
were treated with uranyl acetate and lead citrate, and then examined
with an electron microscope (Philips EM 400, Eindhoven,
The Netherlands).
Lipid analysis
For the extraction of epidermal lipids and eicosanoids, epidermis
samples were dissected and snap-frozen in liquid nitrogen.
Sphingolipids and eicosanoids were extracted according to Zheng
et al. (2011). High-performance thin-layer chromatography separa-
tion of lipids, HPLC-MS/MS, and LC-MS/MS analysis were performed
as described earlier (Deems et al., 2007; Gelhaus et al., 2011;
Jennemann et al., 2012) and in Supplementary Materials and
Methods online.
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